Zampino, Giuseppe
Agostino Gemelli University Polyclinic · Istituti di Ricovero e Cura a Carattere Scientifico
7 papers on CoChatORCID 0000-0002-2661-4831
Most cited papers
- Verified
Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease
Tartaglia, M., Martinelli, S., Stella, L., Bocchinfuso, G., Flex, E., Cordeddu, V., Zampino, G., van der Burgt, I., Palleschi, A., Petrucci, T. C., et al. (2006) · The American Journal of Human Genetics
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 415
- Verified
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: Molecular diversity and associated phenotypic spectrum
Sarkozy, A., Carta, C., Moretti, S., Zampino, G., Digilio, M. C., Pantaleoni, F., Scioletti, A. P., Esposito, G., Cordeddu, V., Lepri, F., et al. (2009) · Human Mutation
Protein Tyrosine PhosphatasesGenomics and Rare Diseases
Cited by 303
- Verified
Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype
Martinelli, S., De Luca, A., Stellacci, E., Rossi, C., Checquolo, S., Lepri, F., Caputo, V., Silvano, M., Buscherini, F., Consoli, F., et al. (2010) · The American Journal of Human Genetics
Protein Tyrosine PhosphatasesGenomics and Rare Diseases
Cited by 259
- Verified
Cognitive profile of disorders associated with dysregulation of the RAS/MAPK signaling cascade
Cesarini, L., Alfieri, P., Pantaleoni, F., Vasta, I., Cerutti, M., Petrangeli, V., Mariotti, P., Leoni, C., Ricci, D., Vicari, S., et al. (2009) · American Journal of Medical Genetics Part A
Protein Tyrosine PhosphatasesGenetics and Neurodevelopmental Disorders
Cited by 98
- Verified
Heterozygous germline mutations in A2ML1 are associated with a disorder clinically related to Noonan syndrome
Vissers, L. E., Bonetti, M., Paardekooper Overman, J., Nillesen, W. M., Frints, S. G. M., de Ligt, J., Zampino, G., Justino, A., Machado, J. C., Schepens, M., et al. (2015) · European Journal of Human Genetics
Protein Tyrosine PhosphatasesGenomics and Rare Diseases
Cited by 75
- Verified
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome
Goeldner, C., Kishnani, P. S., Skotko, B. G., Casero, J. L., Hipp, J. F., Derks, M., Hernandez, M.-C., Khwaja, O., Lennon-Chrimes, S., Noeldeke, J., et al. (2022) · Journal of Neurodevelopmental Disorders
Down syndrome and intellectual disability researchAlzheimer's disease research and treatments
Cited by 48
- Verified
Endocrinologic Dysfunctions and Neuropsychiatric Sequelae in Pediatric Patients with a History of Central Nervous System Infection (ENDLESS): A Prospective Monocentric Study
Sodero, G., Cipolla, C., Camporesi, A., Martino, L., Costa, S., Cannioto, Z., Frassanito, P., Tamburrini, G., Veredice, C., Maggio, L., et al. (2025) · Pediatric Infectious Disease Journal
Infectious Encephalopathies and EncephalitisBacterial Infections and Vaccines
Cited by 11
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free